Macrogen, Inc. (KOSDAQ:038290)
South Korea · Delayed Price · Currency is KRW 12,160
-310 (-2.49%)
Oct 8, 2026, 3:00 PM KST
Macrogen Market Cap
Macrogen has a market cap or net worth of 131.83 billion as of October 7, 2026. That makes Macrogen the world's 25,515th most valuable company and 1,135th in South Korea. Its market cap has decreased by 21.50% in one year.
Market Cap
131.83B
Enterprise Value
178.33B
Revenue
201.62B
Global Rank
Country Rank
#1,135 South Korea
PE Ratio
13.14
ChartMarket Cap Chart
Since September 14, 2000, Macrogen's market cap has decreased from 148.29B to 131.83B, a decrease of -11.10%. That is a compound annual growth rate of -0.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 131.83B | -27.92% |
| Dec 30, 2025 | 182.89B | 11.21% |
| Dec 30, 2024 | 164.45B | -21.52% |
| Dec 28, 2023 | 209.56B | 8.16% |
| Dec 29, 2022 | 193.74B | -33.59% |
| Dec 30, 2021 | 291.72B | 9.42% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 59.05T |
| Celltrion | 41.92T |
| ALTEOGEN | 17.90T |
| Samsung Epis Holdings | 9.16T |
| Ilyang Pharmaceutical Co.,Ltd | 145.19B |
| Genexine | 137.12B |
| SAMSUNG PHARM. Co., LTD. | 134.97B |
| Dongbang Medical | 133.56B |